权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

NCI NCTN-Network Lead Academic Participating Site at UPMC Hillman Cancer Center

UPMC 希尔曼癌症中心 NCI NCTN 网络领导学术参与站点

基本信息

批准号：
10582598
负责人：
ADAM M BRUFSKY
金额：
$ 91.11万
依托单位：
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-05-01 至 2025-02-28
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10582598
关键词：
Academic Medical Centers Address Adult American College of Radiology Imaging Network Cancer Center Cancer Patient Clinical Clinical Data Clinical Investigator Clinical Protocols Clinical Research Clinical Trials Clinical Trials Network Comprehensive Cancer Center Country Development Eastern Cooperative Oncology Group Ensure Genotype Goals Infrastructure Lead Leadership Medical Mentors Minority National Cancer Institute National Clinical Trials Network New York Ohio Oncology Participant Patients Pennsylvania Performance Phase Physicians Positioning Attribute Principal Investigator Process Protocols documentation Publications Reporting Research Personnel Resources Rural Science Services Site Special Population Structure University of Pittsburgh Cancer Institute Work cancer care cancer research center director clinical investigation data management improved process improvement programs rare cancer skills translational scientist

项目摘要

Project Summary/Abstract The goal of the National Clinical Trials Network (NCTN) Lead Academic Participating Site at UPMC Hillman Cancer Center, is to increase our level of participation in conceptualization, development, activation, performance, and reporting of the late-phase clinical trials of the NRG Oncology, ECOG-ACRIN, and Alliance for Clinical Trials in Oncology Network Groups. This will be accomplished by enhancing the quality of our scientific and administrative leadership; increasing accruals to NCTN trials, with special efforts directed at minority, rural and other special populations; improving our processes for rapid activation of new trials, with special efforts directed at trials for rare cancers and genotypically-defined subpopulations; and mentoring junior investigators in how to conduct phase 2 and phase 3 NCTN trials, and in the administrative, scientific, and interpersonal skills needed for advancing into positions of leadership within the NCTN and National Cancer Institute.

项目摘要/摘要国家临床试验网络(NCTN)在UPMC Hillman的领先学术参与网站的目标癌症中心，是为了提高我们在概念化、发展、激活、 NRG肿瘤学、ECOG-ACRIN的后期临床试验的性能和报告肿瘤学网络小组临床试验联盟。这将通过提高质量来实现我们的科学和行政领导地位；通过特别努力，增加NCTN试验的应计收入针对少数民族、农村和其他特殊人群；改进我们的流程，以迅速激活新的试验，特别是针对罕见癌症和基因定义的亚群的试验；指导初级调查人员如何进行NCTN第二阶段和第三阶段试验，以及在行政管理方面，在NCTN内晋升到领导职位所需的科学和人际交往技能以及美国国家癌症研究所。